KA/EN
Register
Medicines reference
Search
Search
Product

Shieria

Favourites

Maropitant · Armavir Biofactory

1 form: solution. In force in Georgia: 1 of 1 (veterinary register).

Forms and doses1 of 1 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Choose species and weight; the matching row will be highlighted.
Form Species Dose Frequency Georgia
Solution · Cat Cat 0.1 ml/kg
Administer subcutaneously or by slow intravenous injection. Do not use in dogs below 8 weeks or cats below 16 weeks. Use caution in hepatic disease or heart failure; not recommended during pregnancy or lactation.
 · once daily for no more than 5 days		 once daily for no more than 5 days Georgia Yes, veterinary
In force until 25 Apr 2030
Veterinary (National Food Agency)
In the register: შიერია®
№ 000836
Verified on: 21 Oct 2026
Solution · Dog Dog 0.1 ml/kg
Administer subcutaneously or by slow intravenous injection. Do not use in dogs below 8 weeks or cats below 16 weeks. Use caution in hepatic disease or heart failure; not recommended during pregnancy or lactation.
 · once daily for no more than 5 days		 once daily for no more than 5 days Georgia Yes, veterinary
In force until 25 Apr 2030
Veterinary (National Food Agency)
In the register: შიერია®
№ 000836
Verified on: 21 Oct 2026
Details: pack, label wording, sources, registration

Shieria, Solution

maropitant 10 mg/ml injection, 10 ml for dogs and cats
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Full dog label from 8 weeks: prevention and treatment of vomiting with maropitant 1 mg/kg (0.1 ml/kg) SC or by slow IV injection once daily for up to 5 days
6.3/10
Situational / acceptable
vetman assessment

Shieria

maropitant 10 mg/ml injection, 10 ml for dogs and cats
Assessed clinical scopeDog · Full dog label from 8 weeks: prevention and treatment of vomiting with maropitant 1 mg/kg (0.1 ml/kg) SC or by slow IV injection once daily for up to 5 days · subcutaneous,intravenous
Care settingClinic or hospital antiemetic treatment alongside diagnosis of the cause of vomiting and supportive care
vetman score 6.3/10 Situational / acceptable
Evidence confidence: Low Georgia: Yes, veterinary · № 000836 · Verified on 21 Oct 2026

A situational generic maropitant: the drug class is excellent, but this product's quality and equivalence to the EU reference are not independently shown. Use it where an EU-authorised maropitant is not available, and always look for the cause of vomiting.

Regulatory and scientific credibility5.0/10

The exact product is registered in Georgia (000836, valid to 2030) from a Russian state biofactory, and its dose and age limits match the EU-authorised maropitant reference (Cerenia), but no bioequivalence or product data are public and the catalogue source is the maker's home page.

Clinical efficacy6.5/10

Maropitant at 1 mg/kg is a well-proven NK1-receptor antiemetic in dogs, so the class evidence is strong; equivalence of this formulation to the reference is assumed, not shown.

Safety and tolerability7.0/10

Maropitant is well tolerated at label dose; the label advises caution in liver disease and heart failure and advises against use in pregnancy or lactation, and subcutaneous injection can sting.

Clinical practicality7.0/10

One daily injection of 0.1 ml/kg from a 10 ml vial suits clinic use well, but it stops vomiting without treating its cause.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Do not use in dogs under 8 weeks; avoid in pregnancy and lactation.
  • Use with caution in liver disease or heart failure; maropitant is cleared by the liver and has affinity for cardiac ion channels.
  • Stopping vomiting can hide obstruction, toxin ingestion or other serious disease; investigate before repeating doses.
  • Do not give for more than 5 consecutive days.
  • Subcutaneous injection may sting; inject steadily with gentle restraint.
Assessment sources
  1. Shieria instruction
  2. Georgia NFA register 20262026
  3. EMA Cerenia EPAR2024
  4. Merck Vet Manual antiemetics2026
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Full cat label from 16 weeks: prevention and treatment of vomiting with maropitant 1 mg/kg (0.1 ml/kg) SC or by slow IV injection once daily for up to 5 days
6.1/10
Situational / acceptable
vetman assessment

Shieria

maropitant 10 mg/ml injection, 10 ml for dogs and cats
Assessed clinical scopeCat · Full cat label from 16 weeks: prevention and treatment of vomiting with maropitant 1 mg/kg (0.1 ml/kg) SC or by slow IV injection once daily for up to 5 days · subcutaneous,intravenous
Care settingClinic or hospital antiemetic treatment alongside diagnosis of the cause of vomiting and supportive care
vetman score 6.1/10 Situational / acceptable
Evidence confidence: Low Georgia: Yes, veterinary · № 000836 · Verified on 21 Oct 2026

A situational generic maropitant for cats: the drug class works well, but this product's quality and equivalence to the EU reference are not independently shown. Use it where an EU-authorised maropitant is not available, and always look for the cause of vomiting.

Regulatory and scientific credibility5.0/10

The exact product is registered in Georgia (000836, valid to 2030) from a Russian state biofactory, and its dose and age limits match the EU-authorised maropitant reference (Cerenia), but no bioequivalence or product data are public and the catalogue source is the maker's home page.

Clinical efficacy6.5/10

Maropitant at 1 mg/kg is an effective NK1-receptor antiemetic in cats, so the class evidence is strong; equivalence of this formulation to the reference is assumed, not shown.

Safety and tolerability6.5/10

Maropitant is generally well tolerated in cats at label dose; the label sets a 16-week minimum age and advises caution in liver disease and heart failure, and injection pain is common.

Clinical practicality6.5/10

A daily 0.1 ml/kg injection is easy in clinic, though a small cat needs a precisely measured volume and the injection can sting.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Do not use in cats under 16 weeks; avoid in pregnancy and lactation.
  • Use with caution in liver disease or heart failure; maropitant is cleared by the liver and has affinity for cardiac ion channels.
  • Stopping vomiting can hide obstruction, a linear foreign body or toxin ingestion; investigate before repeating doses.
  • Do not give for more than 5 consecutive days; measure small volumes with a 1 ml syringe.
  • Subcutaneous injection may sting; inject steadily with gentle restraint.
Assessment sources
  1. Shieria instruction
  2. Georgia NFA register 20262026
  3. EMA Cerenia EPAR2024
  4. Merck Vet Manual antiemetics2026
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Maropitant10 mg/ml
Formulation Type
Solution
Administration route
subcutaneous, intravenous
Manufacturer
Armavir Biofactory
Manufacturer (register)
Federal Treasury Enterprise Armavir Biofactory, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1369, 19 Oct 2026.
Source: NFA veterinary medicines register ↗
Registration
Georgia Yes, veterinary
In force until 25 Apr 2030
Veterinary (National Food Agency)
In the register: შიერია®
№ 000836
Verified on: 21 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
DoseSpeciesWeightRouteFrequencySource
0.1 ml/kg
Administer subcutaneously or by slow intravenous injection. Do not use in dogs below 8 weeks or cats below 16 weeks. Use caution in hepatic disease or heart failure; not recommended during pregnancy or lactation.
 Cat Any weight subcutaneous,intravenous once daily for no more than 5 days
Shieria instruction
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Shieria maropitant injection - current official instruction
Official manufacturer product instruction
0.1 ml/kg
Administer subcutaneously or by slow intravenous injection. Do not use in dogs below 8 weeks or cats below 16 weeks. Use caution in hepatic disease or heart failure; not recommended during pregnancy or lactation.
 Dog Any weight subcutaneous,intravenous once daily for no more than 5 days
Shieria instruction
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Shieria maropitant injection - current official instruction
Official manufacturer product instruction
Active substance doses, with sources
Active substance Maropitant
Dose calculatorCalculates the active-substance amount; it is not a prescription.
PatientSpecies and weight will be filled in automatically in other calculators.
Selected dose
Dose Species Indication Route Frequency Source
1 mg/kg Dog, Cat Vomiting Intravenous / Subcutaneous once daily
VMD SPC 2024
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Vetemex 10 mg/ml Solution for Injection for Dogs and Cats - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2024

Known Contraindications

  • Warning
    Maropitant is metabolised in the liver and therefore should be used with caution in patients with hepatic disease. As maropitant is accumulated in the body during a 14 day treatment period due to metabolic saturation, careful monitoring of liver function and any adverse events should be implemented during long term treatment.
    Sources: VMD SPC · VMD
  • Warning
    The veterinary medicinal product should be used with caution in animals suffering from or with predisposition for cardiac diseases as maropitant has affinity to Ca- and K-ion channels.
    Sources: VMD SPC · VMD
  • Warning
    Vomiting can be associated with serious, severely debilitating conditions including gastrointestinal obstructions; therefore, appropriate diagnostic evaluations should be employed.
    Sources: VMD SPC · VMD
  • Warning
    Use only according to the benefit-risk assessment by the responsible veterinarian, because conclusive reproductive toxicity studies have not been conducted in any animal species.
    Sources: VMD SPC · VMD
  • Warning
    The safety of maropitant has not been established in... pregnant or lactating dogs and cats.
    Sources: VMD SPC · VMD
  • Warning (Dog)
    The safety of maropitant has not been established in dogs less than 8 weeks of age, or in cats less than 16 weeks of age.
    Sources: VMD SPC · VMD
  • Warning (Cat)
    The safety of maropitant has not been established in dogs less than 8 weeks of age, or in cats less than 16 weeks of age.
    Sources: VMD SPC · VMD

Known Drug Interactions

  • Major warning Amlodipine + Maropitant
    The veterinary medicinal product should not be used concomitantly with Ca-channel antagonists as maropitant has affinity to Ca-channels.
    Recommendation: None
    Sources: VMD SPC · VMD

Products are connected by name, active ingredients, or therapeutic group. They are not direct substitutes for one another.

Show all related products (41 more) Hide additional products

Same therapeutic group 41

Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.

For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.

Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.

The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.

This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 21 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.

Register Demo ↗